Literature DB >> 27062327

Use of Population-based Data to Demonstrate How Waitlist-based Metrics Overestimate Geographic Disparities in Access to Liver Transplant Care.

D S Goldberg1,2,3, B French2,3, G Sahota4, A E Wallace4, J D Lewis1,2,3, S D Halpern2,3,5.   

Abstract

Liver allocation policies are evaluated by how they impact waitlisted patients, without considering broader outcomes for all patients with end-stage liver disease (ESLD) not on the waitlist. We conducted a retrospective cohort study using two nationally representative databases: HealthCore (2006-2014) and five-state Medicaid (California, Florida, New York, Ohio and Pennsylvania; 2002-2009). United Network for Organ Sharing (UNOS) linkages enabled ascertainment of waitlist- and transplant-related outcomes. We included patients aged 18-75 with ESLD (decompensated cirrhosis or hepatocellular carcinoma) using validated International Classification of Diseases, Ninth Revision (ICD-9)-based algorithms. Among 16 824 ESLD HealthCore patients, 3-year incidences of waitlisting and transplantation were 15.8% (95% confidence interval [CI] : 15.0-16.6%) and 8.1% (7.5-8.8%), respectively. Among 67 706 ESLD Medicaid patients, 3-year incidences of waitlisting and transplantation were 10.0% (9.7-10.4%) and 6.7% (6.5-7.0%), respectively. In HealthCore, the absolute ranges in states' waitlist mortality and transplant rates were larger than corresponding ranges among all ESLD patients (waitlist mortality: 13.6-38.5%, ESLD 3-year mortality: 48.9-62.0%; waitlist transplant rates: 36.3-72.7%, ESLD transplant rates: 4.8-13.4%). States' waitlist mortality and ESLD population mortality were not positively correlated: ρ = -0.06, p-value = 0.83 (HealthCore); ρ = -0.87, p-value = 0.05 (Medicaid). Waitlist and ESLD transplant rates were weakly positively correlated in Medicaid (ρ = 0.36, p-value = 0.55) but were positively correlated in HealthCore (ρ = 0.73, p-value = 0.001). Compared to population-based metrics, waitlist-based metrics overestimate geographic disparities in access to liver transplantation. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  disparities; epidemiology; ethics and public policy; health services and outcomes research; liver transplantation/hepatology; organ allocation; organ procurement and allocation

Mesh:

Year:  2016        PMID: 27062327      PMCID: PMC5055842          DOI: 10.1111/ajt.13820

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  33 in total

1.  Solid-organ transplantation in HIV-infected patients.

Authors:  Scott D Halpern; Peter A Ubel; Arthur L Caplan
Journal:  N Engl J Med       Date:  2002-07-25       Impact factor: 91.245

Review 2.  Using Telehealth to Enable Patient-Centered Care for Liver Transplantation.

Authors:  Audrey E Ertel; Tiffany Kaiser; Shimul A Shah
Journal:  JAMA Surg       Date:  2015-07       Impact factor: 14.766

3.  Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death.

Authors:  Elisabetta Patorno; Rhonda L Bohn; Peter M Wahl; Jerry Avorn; Amanda R Patrick; Jun Liu; Sebastian Schneeweiss
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

4.  Addressing geographic disparities in liver transplantation through redistricting.

Authors:  S E Gentry; A B Massie; S W Cheek; K L Lentine; E H Chow; C E Wickliffe; N Dzebashvili; P R Salvalaggio; M A Schnitzler; D A Axelrod; D L Segev
Journal:  Am J Transplant       Date:  2013-07-09       Impact factor: 8.086

5.  An Automated Telephone Monitoring System to Identify Patients with Cirrhosis at Risk of Re-hospitalization.

Authors:  Mary Thomson; Michael Volk; Hyungjin Myra Kim; John D Piette
Journal:  Dig Dis Sci       Date:  2015-06-13       Impact factor: 3.199

6.  Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database.

Authors:  D Goldberg; Jd Lewis; Sd Halpern; Mark Weiner; Vincent Lo Re
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-06-04       Impact factor: 2.890

7.  Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities.

Authors:  Ponni V Perumalswami; Stephanie H Factor; Luciano Kapelusznik; Scott L Friedman; Calvin Q Pan; Charissa Chang; Frances Di Clemente; Douglas T Dieterich
Journal:  J Hepatol       Date:  2013-01-15       Impact factor: 25.083

8.  Sociodemographic differences in early access to liver transplantation services.

Authors:  C L Bryce; D C Angus; R M Arnold; C-C H Chang; M H Farrell; C Manzarbeitia; I R Marino; M S Roberts
Journal:  Am J Transplant       Date:  2009-07-23       Impact factor: 8.086

9.  Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database.

Authors:  David S Goldberg; James D Lewis; Scott D Halpern; Mark G Weiner; Vincent Lo Re
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-11-04       Impact factor: 2.890

10.  Distributing scarce livers: the moral reasoning of the general public.

Authors:  P A Ubel; G Loewenstein
Journal:  Soc Sci Med       Date:  1996-04       Impact factor: 4.634

View more
  15 in total

1.  Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

Authors:  David Goldberg; Ivo C Ditah; Kia Saeian; Mona Lalehzari; Andrew Aronsohn; Emmanuel C Gorospe; Michael Charlton
Journal:  Gastroenterology       Date:  2017-01-11       Impact factor: 22.682

2.  Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.

Authors:  Mary G Bowring; Sheng Zhou; Eric K H Chow; Allan B Massie; Dorry L Segev; Sommer E Gentry
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

Review 3.  Are geographic differences in transplantation inherently wrong?

Authors:  Keren Ladin; Douglas W Hanto
Journal:  Curr Opin Organ Transplant       Date:  2017-04       Impact factor: 2.640

4.  Geographic disparities in liver supply/demand ratio within fixed-distance and fixed-population circles.

Authors:  Christine E Haugen; Tanveen Ishaque; Abel Sapirstein; Alexander Cauneac; Dorry L Segev; Sommer Gentry
Journal:  Am J Transplant       Date:  2019-03-18       Impact factor: 8.086

5.  Increased Distance to a Liver Transplant Center Is Associated With Higher Mortality for Patients With Chronic Liver Failure.

Authors:  David S Goldberg; Craig Newcomb; Richard Gilroy; Gurvaneet Sahota; Anna E Wallace; James D Lewis; Scott D Halpern
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-27       Impact factor: 11.382

6.  Quantifying Sex-Based Disparities in Liver Allocation.

Authors:  Jayme E Locke; Brittany A Shelton; Kim M Olthoff; Elizabeth A Pomfret; Kimberly A Forde; Deirdre Sawinski; Meagan Gray; Nancy L Ascher
Journal:  JAMA Surg       Date:  2020-07-15       Impact factor: 14.766

7.  Advance Care Planning and Goals of Care Discussions in Advanced Liver Disease.

Authors:  Nneka N Ufere
Journal:  Curr Hepatol Rep       Date:  2021-07-21

8.  Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease.

Authors:  David Goldberg; Benjamin French; Craig Newcomb; Qing Liu; Gurvaneet Sahota; Anna E Wallace; Kimberly A Forde; James D Lewis; Scott D Halpern
Journal:  Clin Gastroenterol Hepatol       Date:  2016-06-29       Impact factor: 11.382

Review 9.  Best Practices in Large Database Clinical Epidemiology Research in Hepatology: Barriers and Opportunities.

Authors:  Nadim Mahmud; David S Goldberg; Therese Bittermann
Journal:  Liver Transpl       Date:  2021-08-07       Impact factor: 5.799

10.  County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.

Authors:  David Goldberg; Katherine Ross-Driscoll; Raymond Lynch
Journal:  Gastroenterology       Date:  2020-11-18       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.